china glp-1 patent expiry and new GLP‑1 entries intensify global obesity drug fight As China's drug industry races

When patients begin their medical weight loss journey at Internal Medicine and Family Practice in Joliet, one of their primary questions is how rapidly they will experience a decrease in their appetite

Tirzepatide: This novel medication combines the effects of two different hormones involved in blood sugar regulation and appetite control

GLP-1 injections: Evidence and efficacy In contrast to patches, GLP-1 injections have extensive clinical evidence supporting their effectiveness: Clinical trial results Wegovy (semaglutide) : The STEP clinical trials involved thousands of participants and showed average weight loss of 15% after 68 weeks

We recognize that each patients journey is unique

GLP-1 is no exception

Management of Diabetes in Pregnancy: Standards of Care in Diabetes2026